Importance A promising treatment to prevent onset and improve outcomes in patients at
ultrahigh risk for psychosis is dietary supplementation with long-chain ω-3 polyunsaturated …

Context The use of antipsychotic medication for the prevention of psychotic disorders is
controversial. Long-chain ω-3 (omega-3) polyunsaturated fatty acids (PUFAs) may be …

Long-chain omega-3 polyunsaturated fatty acids (PUFAs) are essential for neural
development and function. As key components of brain tissue, omega-3 PUFAs play critical …

Background NEURAPRO was a multicenter, placebo-controlled trial of long-chain omega-3
polyunsaturated fatty acids (n-3 PUFAs)(fish oil) in 304 individuals at ultra-high risk for …

Objective: To investigate whether long-chain omega-3 (n-3) polyunsaturated fatty acids
(PUFAs) improve functioning and psychiatric symptoms in young people with borderline …

Background A growing number of observational and epidemiological studies have
suggested that mental illness, in particular mood disorders, is associated with reduced …

Omega-3 treatment studies for multi-episode schizophrenia or clinical high risk for
conversion to psychosis states have had variable, and often negative, results. To examine …

Background Schizophrenia is a serious long-term psychotic disorder marked by positive and
negative symptoms, severe behavioral problems and cognitive function deficits. The cause …

Unsaturated fatty acids might be involved in the prevention of and improvement in mental
disorders, but the evidence on these associations has not been comprehensively assessed …

As an extension of the early intervention in psychosis paradigm, different focused treatments
are now offered to individuals at ultra high risk of psychosis (UHR) to prevent transition to …